Search research articles
Contact Us
Filters
Showing results (1451-1460 of 1,873) with videos related to
Page
of 188
Sort By:
Journal of the American College of Cardiology
|
August 3, 2019
Age-Related Characteristics and Outcomes of Patients With Heart Failure With Preserved Ejection Fraction
Jasper Tromp, Li Shen, Pardeep S Jhund, et al.
JACC. Heart Failure
|
January 4, 2023
Blood Pressure and Dapagliflozin in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: DELIVER
Senthil Selvaraj, Muthiah Vaduganathan, Brian L Claggett, et al.
Circulation
|
October 20, 2004
Mortality and morbidity reduction with Candesartan in patients with chronic heart failure and left ventricular systolic dysfunction: results of the CHARM low-left ventricular ejection fraction trials
James B Young, Mark E Dunlap, Marc A Pfeffer, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 16, 2014
Synergistic tumor suppression by combined inhibition of telomerase and CDKN1A
Romi Gupta, Yuying Dong, Peter D Solomon, et al.
European Journal of Heart Failure
|
September 30, 2017
Prognostic importance of emerging cardiac, inflammatory, and renal biomarkers in chronic heart failure patients with reduced ejection fraction and anaemia: RED-HF study
Paul Welsh, Lei Kou, Changhong Yu, et al.
Genes and Immunity
|
January 13, 2019
Mother-child histocompatibility and risk of rheumatoid arthritis and systemic lupus erythematosus among mothers
Giovanna I Cruz, Xiaorong Shao, Hong Quach, et al.
JACC. Heart Failure
|
August 26, 2025
Temporal Changes in Biomarkers, Functional Status, and Quality of Life Prior to Adverse Clinical Outcomes in Heart Failure With Mildly Reduced or Preserved Ejection Fraction
Henri Lu, Brian L Claggett, Muthiah Vaduganathan, et al.
Journal of the American College of Cardiology
|
August 1, 2020
Effect of Sacubitril/Valsartan on Biomarkers of Extracellular Matrix Regulation in Patients With HFpEF
Jonathan W Cunningham, Brian L Claggett, Eileen O'Meara, et al.
NEJM Evidence
|
November 10, 2025
Digital Nudges to Increase Influenza Vaccination in Patients with Chronic Diseases
Niklas Dyrby Johansen, Muthiah Vaduganathan, Ankeet S Bhatt, et al.
JACC. Heart Failure
|
December 15, 2023
Left Ventricular Ejection Fraction and the Future of Heart Failure Phenotyping
Matthew G Dimond, Nasrien E Ibrahim, Mona Fiuzat, et al.
Page
of 188
Search research articles
Search
Showing results (1451-1460 of 1,873) with videos related to
Sort By:
Page
of 188
Journal of the American College of Cardiology
|
August 3, 2019
Age-Related Characteristics and Outcomes of Patients With Heart Failure With Preserved Ejection Fraction
Jasper Tromp, Li Shen, Pardeep S Jhund, et al.
JACC. Heart Failure
|
January 4, 2023
Blood Pressure and Dapagliflozin in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: DELIVER
Senthil Selvaraj, Muthiah Vaduganathan, Brian L Claggett, et al.
Circulation
|
October 20, 2004
Mortality and morbidity reduction with Candesartan in patients with chronic heart failure and left ventricular systolic dysfunction: results of the CHARM low-left ventricular ejection fraction trials
James B Young, Mark E Dunlap, Marc A Pfeffer, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 16, 2014
Synergistic tumor suppression by combined inhibition of telomerase and CDKN1A
Romi Gupta, Yuying Dong, Peter D Solomon, et al.
European Journal of Heart Failure
|
September 30, 2017
Prognostic importance of emerging cardiac, inflammatory, and renal biomarkers in chronic heart failure patients with reduced ejection fraction and anaemia: RED-HF study
Paul Welsh, Lei Kou, Changhong Yu, et al.
Genes and Immunity
|
January 13, 2019
Mother-child histocompatibility and risk of rheumatoid arthritis and systemic lupus erythematosus among mothers
Giovanna I Cruz, Xiaorong Shao, Hong Quach, et al.
JACC. Heart Failure
|
August 26, 2025
Temporal Changes in Biomarkers, Functional Status, and Quality of Life Prior to Adverse Clinical Outcomes in Heart Failure With Mildly Reduced or Preserved Ejection Fraction
Henri Lu, Brian L Claggett, Muthiah Vaduganathan, et al.
Journal of the American College of Cardiology
|
August 1, 2020
Effect of Sacubitril/Valsartan on Biomarkers of Extracellular Matrix Regulation in Patients With HFpEF
Jonathan W Cunningham, Brian L Claggett, Eileen O'Meara, et al.
NEJM Evidence
|
November 10, 2025
Digital Nudges to Increase Influenza Vaccination in Patients with Chronic Diseases
Niklas Dyrby Johansen, Muthiah Vaduganathan, Ankeet S Bhatt, et al.
JACC. Heart Failure
|
December 15, 2023
Left Ventricular Ejection Fraction and the Future of Heart Failure Phenotyping
Matthew G Dimond, Nasrien E Ibrahim, Mona Fiuzat, et al.
Page
of 188